Cooper C. Collins
Chief Executive Officer
Description:
Cooper C. Collins, MBA, serves as the Managing Partner and CIO of MagnaSci Venture funds and as an advisor to a number of pharmaceutical and biotechnology companies. He is a founder of Pernix Therapeutics Holdings, Inc, (PTX: NASDAQ), a specialty pharmaceutical company focused on branded, generic, and OTC products. Mr. Collins was a member of the Pernix Board of Directors from 2007 to 2014 and served as President and CEO from 2008 to 2013. Mr. Collins also serves as a Board Member and as Chairman of the Compensation Committee for TherapeuticsMD, Inc, (TXMD:NYSE MKT), a healthcare company focused on developing and commercializing products targeted exclusively for women.
Want to contact Cooper C. Collins?
Feel free to contact us to make you prepared.
Summary:
Cooper C. Collins, MBA, serves as the Managing Partner and CIO of MagnaSci Venture funds and as an advisor to a number of pharmaceutical and...
Number of Registered Investments:1
Contact Details:
- Address: Houston, Texas, United States
- No email is provided
Location:Houston, Texas, United States
Email is Not Provided
Phone Number:Houston, Texas, United States
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.